European Economic News Preview: Spain Final Inflation Data Due
https://www.rttnews.com/3432055/european-economic-news-preview-spain-final-inflation-data-due.aspx?type=alleco
Mar 13, 2024 - Final consumer price data from Spain is due on Thursday, headlining a very light day for the European economic news. At 3.00 am ET, Statistics Sweden releases consumer prices for February. Inflation is forecast to ease to 4.7 percent from 5.4 percent in January.
0
Officials hope Facebook parent Meta's data center spurs more Rosemount projects
https://www.startribune.com/meta-data-center-rosemount-minnesota-800-million-clean-energy/600351089/
Mar 14, 2024 - Site work on the $800 million project will begin this month.
0
European Economic News Preview: France Final Inflation Data Due
https://www.rttnews.com/3432460/european-economic-news-preview-france-final-inflation-data-due.aspx?type=alleco
Mar 14, 2024 - Final consumer price inflation figures are due from France on Friday, headlining a light day for the European economic news. At 3.00 am ET, foreign trade from Norway and unemployment figures from Sweden are due. At 3.45 am ET, France's statistical office INSEE is scheduled to issue final consumer and harmonized prices figures for February.
0
Pre-Markets Up Ahead of FOMC, Housing Data and Jensen Huang
https://www.zacks.com/stock/news/2242231/pre-markets-up-ahead-of-fomc-housing-data-and-jensen-huang?cid=CS-ZC-FT-ahead_of_wall_street-2242231
Mar 18, 2024 - Apparently, market participants are expecting good things for the tech sector this week.
0
Recursion: Exercising Caution Prior To Q3 Data Release (Rating Downgrade)
https://seekingalpha.com/article/4679244-recursion-rxrx-stock-exercising-caution-prior-to-q3-data-release?source=feed_all_articles
Mar 19, 2024 - Recursion Pharmaceuticals' 35% stock price rise was driven by investments from NVIDIA and Roche. Explore more here to learn about RXRX stock's hold rating.
0
FibroBiologics reports encouraging early data for diabetes cell therapy
https://seekingalpha.com/news/4081197-fibrobiologics-reports-encouraging-early-data-for-diabetes-cell-therapy?source=feed_sector_healthcare
Mar 19, 2024 - Newly public FibroBiologics (FBLG) has reported encouraging results from an early proof-of-concept study for a potential cell therapy for diabetes. Read more here.
0
Hoth stock rallies 24% on preclinical Alzheimer's data
https://seekingalpha.com/news/4081167-hoth-stock-rallies-on-preclinical-alzheimers-data?source=feed_sector_healthcare
Mar 19, 2024 - Hoth (HOTH) stock rallied 24% Tuesday after the company reported positive preclinical data for its drug candidate HT-ALZ in the treatment of Alzheimer’s disease. Read more here.
0
Housing Market Data Shows Bounce-Back in February
https://www.zacks.com/stock/news/2242868/housing-market-data-shows-bounce-back-in-february?cid=CS-ZC-FT-ahead_of_wall_street-2242868
Mar 19, 2024 - Mortgage rates have drifted back up to the 7% range, expectations are for lower interest rates from the Fed at some point this year.
0
New Zealand GDP Data Due On Thursday
https://www.rttnews.com/3433307/new-zealand-gdp-data-due-on-thursday.aspx?type=alleco
Mar 20, 2024 - New Zealand will on Thursday release Q4 figures for gross domestic product, highlighting a busy day for Asia-Pacific economic activity.
0
ACELYRIN (SLRN) Up on Data From Thyroid Eye Disease Study
https://www.zacks.com/stock/news/2244204/acelyrin-slrn-up-on-data-from-thyroid-eye-disease-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2244204
Mar 21, 2024 - ACELYRIN (SLRN) posts positive proof-of-concept data from a phase I/II study evaluating its pipeline candidate, lonigutamab, for treating thyroid eye disease. Stock gains.
0